 Deutsche Bank AG grew its holdings in CymaBay Therapeutics Inc NASDAQ:CBAY by 474.1 during the 1st quarter, according to its most recent Form 13F filing with the Securities Exchange Commission. The institutional investor owned 3,154,427 shares of the biopharmaceutical companys stock after acquiring an additional 2,605,008 shares during the period. Deutsche Bank AGs holdings ... 